AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36174006 — intervention group
Group type: EXPERIMENTAL
Intervention: Tritipyrum lines
Number of subjects: 17
Study 36174006 — intervention group
Group type: EXPERIMENTAL
Intervention: M45 triticale and tritipyrum (Ka/b)(Cr/b)‐5
Number of subjects: 17
Study 36174006 — intervention group
Group type: EXPERIMENTAL
Intervention: Spike number
Number of subjects: 17
Study 33618721 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation education through social media (WhatsApp channel and group) for 1 month
Number of subjects: 60
Study 33618721 — intervention group
Group type: COMPARATOR
Intervention: Control group received discharge education via pamphlets and face-to-face training
Number of subjects: 60
Study 36214032 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (120 kVp, 370 mgI/ml CM)
Number of subjects: 150
Study 36214032 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (100 kVp, 350 mgI/ml CM)
Number of subjects: 150
Study 36214032 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (80 kVp, 320 mgI/ml CM)
Number of subjects: 150
Study 34036845 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonists (Triptorelin or Leuprorelin 3.75 mg every 4 weeks for 6 months)
Number of subjects: 146
Study 34036845 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest (2 mg/day for at least 6 months)
Number of subjects: 146
Study 32059943 — intervention group
Group type: EXPERIMENTAL
Intervention: Revision cubital tunnel surgery
Number of subjects: 17
Study 32059943 — intervention group
Group type: COMPARATOR
Intervention: Primary cubital tunnel surgery (control cohort)
Number of subjects: 17
Study 34296334 — intervention group
Group type: EXPERIMENTAL
Intervention: CSNAT-I (Carer Support Needs Assessment Tool Intervention)
Number of subjects: 130
Study 33567657 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent communication with devices
Number of subjects: 725
Study 33567657 — intervention group
Group type: COMPARATOR
Intervention: Infrequent communication with devices
Number of subjects: 725
Study 33567657 — intervention group
Group type: COMPARATOR
Intervention: No communication devices
Number of subjects: 725
Study 32519832 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (PLY) once a week for 12 weeks
Number of subjects: 16
Study 32519832 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 16
Study 34854308 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4330
Study 34854308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4330
Study 34854308 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GDF-15 levels
Number of subjects: 4330
Study 36058695 — intervention group
Group type: EXPERIMENTAL
Intervention: Common burn diet enteral immunonutrition group (n=225)
Number of subjects: 500
Study 36058695 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe burn diet enteral immunonutrition group (n=23)
Number of subjects: 500
Study 32725293 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 portions of fish per week (140 g per portion)
Number of subjects: 49
Study 32725293 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 portion of fish per week (140 g per portion)
Number of subjects: 49
Study 32725293 — intervention group
Group type: COMPARATOR
Intervention: No fish
Number of subjects: 49
Study 35710254 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiplin digital intervention
Number of subjects: 50
Study 35710254 — intervention group
Group type: COMPARATOR
Intervention: Usual supervised physical activity programme
Number of subjects: 50
Study 33293297 — intervention group
Group type: EXPERIMENTAL
Intervention: Average accelerations (accelerometer-based physical activity)
Number of subjects: 0
Study 33293297 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous physical activity (fraction of accelerations >425 milligravities)
Number of subjects: 0
Study 33293297 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behavior (metabolic equivalent task ≤1.5)
Number of subjects: 0
Study 36445316 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led motor function rehabilitation program (7 consecutive days, twice daily for 30 minutes)
Number of subjects: 104
Study 36445316 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 104
Study 34110395 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncologist-directed interventions to facilitate discussion of emotions
Number of subjects: 141
Study 34110395 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-directed interventions to facilitate discussion of emotions
Number of subjects: 141
Study 34110395 — intervention group
Group type: EXPERIMENTAL
Intervention: General oncologist treatment style
Number of subjects: 141
Study 34523017 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion reirradiation (CIRT) - 45 Gy (RBE; 15 fractions)
Number of subjects: 78
Study 34523017 — intervention group
Group type: COMPARATOR
Intervention: Photon reirradiation (FSRT) - 39 Gy (13 fractions)
Number of subjects: 78
Study 34523017 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of CIRT vs FSRT
Number of subjects: 78
Study 34523017 — intervention group
Group type: COMPARATOR
Intervention: Adverse events for FSRT
Number of subjects: 78
Study 34523017 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events for CIRT
Number of subjects: 78
Study 32585668 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) reduction (goal 110-139 mm Hg) using intravenous nicardipine
Number of subjects: 1000
Study 32585668 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure (SBP) reduction (goal 140-179 mm Hg)
Number of subjects: 1000
Study 32585668 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) reduction
Number of subjects: 1000
Study 32585668 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure (SBP) reduction
Number of subjects: 1000
Study 36445398 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnenolone 300 mg
Number of subjects: 43
Study 36445398 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnenolone 500 mg
Number of subjects: 43
Study 36445398 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 43
Study 36445398 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnenolone (both doses)
Number of subjects: 43
Study 33612489 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-to-child approach
Number of subjects: 397
Study 33612489 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 397
Study 32830462 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 supplementation (20,400 IU every other day)
Number of subjects: 38
Study 32830462 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose vitamin D3 supplementation (400 IU every other day)
Number of subjects: 38
Study 35611581 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-surgical aerobic dance-based exercise programme (PSADBE) and physical activity counselling (PAC)
Number of subjects: 34
Study 35611581 — intervention group
Group type: COMPARATOR
Intervention: Physical activity counselling (PAC)
Number of subjects: 34
Study 33787191 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft and prolonged massage with Roghan‐i‐Bābūna
Number of subjects: 48
Study 33787191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry cupping on alternate days for 15 minutes
Number of subjects: 48
Study 33787191 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (Soft and prolonged massage and Dry cupping)
Number of subjects: 48
Study 33296549 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CSA) (2.5‐5 mg/kg/d)
Number of subjects: 75
Study 33296549 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) (7.5‐15 mg/week)
Number of subjects: 75
Study 33296549 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin (ACT) (25‐50 mg/d)
Number of subjects: 75
Study 32868146 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathy phonation
Number of subjects: 13
Study 32868146 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral phonation
Number of subjects: 13
Study 32868146 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow phonation
Number of subjects: 13
Study 32868146 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressed phonation
Number of subjects: 13
Study 32868146 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical loudness condition
Number of subjects: 13
Study 32868146 — intervention group
Group type: EXPERIMENTAL
Intervention: Loud loudness condition
Number of subjects: 13
Study 32868146 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft loudness condition
Number of subjects: 13
Study 34552657 — intervention group
Group type: EXPERIMENTAL
Intervention: Viola flower syrup (VFS) for four weeks
Number of subjects: 140
Study 34552657 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG) for four weeks
Number of subjects: 140
Study 36037779 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory application of kinesio tape plus static stretching
Number of subjects: 15
Study 36037779 — intervention group
Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 15
Study 34087150 — intervention group
Group type: EXPERIMENTAL
Intervention: Copanlisib plus rituximab
Number of subjects: 0
Study 34087150 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus rituximab
Number of subjects: 0
Study 32402684 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferrous fumarate (FF) 200 mg three times a day (total daily dose: 195 mg elemental iron)
Number of subjects: 120
Study 32402684 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferrous gluconate (FG) 695 mg twice a day (total daily dose: 160 mg elemental iron)
Number of subjects: 120
Study 32402684 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM) 1000 mg elemental iron (single dose)
Number of subjects: 120
Study 32402684 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferrous fumarate (FF)
Number of subjects: 120
Study 32402684 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferrous gluconate (FG)
Number of subjects: 120
Study 35649301 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial intervention (not specified in detail)
Number of subjects: 89
Study 33127287 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotem
Number of subjects: 59
Study 33127287 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplate
Number of subjects: 59
Study 33127287 — intervention group
Group type: COMPARATOR
Intervention: Cyanotic group
Number of subjects: 59
Study 33127287 — intervention group
Group type: COMPARATOR
Intervention: Acyanotic group
Number of subjects: 59
Study 32780844 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity group (Fitbit intervention)
Number of subjects: 23
Study 32780844 — intervention group
Group type: COMPARATOR
Intervention: Standard care (education-only group)
Number of subjects: 23
Study 33789963 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF therapy during the third trimester of pregnancy
Number of subjects: 176
Study 33789963 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment during the third trimester)
Number of subjects: 176
Study 35777562 — intervention group
Group type: COMPARATOR
Intervention: Air filtration intervention
Number of subjects: 0
Study 35777562 — intervention group
Group type: COMPARATOR
Intervention: Education intervention
Number of subjects: 0
Study 35777562 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0
Study 32869399 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated milk (HM)
Number of subjects: 33
Study 32869399 — intervention group
Group type: COMPARATOR
Intervention: Unheated milk (UM)
Number of subjects: 33
Study 35247098 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat aleurone (27 g/day)
Number of subjects: 67
Study 35247098 — intervention group
Group type: COMPARATOR
Intervention: Cellulose (placebo treatment)
Number of subjects: 67
Study 32045409 — intervention group
Group type: EXPERIMENTAL
Intervention: SEHER intervention delivered by a lay counsellor (SEHER Mitra [SM])
Number of subjects: 15232
Study 32045409 — intervention group
Group type: COMPARATOR
Intervention: Teacher as SEHER Mitra [TSM] intervention
Number of subjects: 15232
Study 32045409 — intervention group
Group type: COMPARATOR
Intervention: Control group (Adolescence Education Program [AEP] alone)
Number of subjects: 15232
Study 35180222 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong warnings with click requirement
Number of subjects: 1500
Study 35180222 — intervention group
Group type: EXPERIMENTAL
Intervention: Weak warnings with click requirement
Number of subjects: 1500
Study 35180222 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong warnings without click requirement
Number of subjects: 1500
Study 35180222 — intervention group
Group type: EXPERIMENTAL
Intervention: Weak warnings without click requirement
Number of subjects: 1500
Study 35180222 — intervention group
Group type: COMPARATOR
Intervention: Control group (no warning)
Number of subjects: 1500
Study 35180222 — intervention group
Group type: EXPERIMENTAL
Intervention: Commonly used TOS warning
Number of subjects: 1500
Study 34182806 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 28
Study 34182806 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 28
Study 32718724 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 10
Study 32718724 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 10
Study 32718724 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Dobutamine and Phenylephrine
Number of subjects: 10
Study 33587110 — intervention group
Group type: EXPERIMENTAL
Intervention: Flortaucipir PET scan with advanced AD pattern
Number of subjects: 364
Study 33587110 — intervention group
Group type: COMPARATOR
Intervention: Flortaucipir PET scan with nonadvanced AD pattern
Number of subjects: 364
Study 33587110 — intervention group
Group type: EXPERIMENTAL
Intervention: Flortaucipir PET scan (advanced AD pattern)
Number of subjects: 364
Study 33587110 — intervention group
Group type: COMPARATOR
Intervention: Flortaucipir PET scan (nonadvanced AD pattern)
Number of subjects: 364
Study 33625468 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous electrocardiographic (cECG) monitoring with standard care.
Number of subjects: 856
Study 33625468 — intervention group
Group type: COMPARATOR
Intervention: Standard care (routine clinical follow-up plus pulse check and heart auscultation).
Number of subjects: 856
Study 33625468 — intervention group
Group type: EXPERIMENTAL
Intervention: Home blood pressure (BP) monitor with oscillometric AF screening capability.
Number of subjects: 856
Study 32275670 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral radiation therapy
Number of subjects: 62
Study 32275670 — intervention group
Group type: COMPARATOR
Intervention: Bilateral radiation therapy
Number of subjects: 62
Study 35286236 — intervention group
Group type: EXPERIMENTAL
Intervention: Guilt Focused Intervention (GFI)
Number of subjects: 42
Study 35286236 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Intervention (CBI)
Number of subjects: 42
Study 32840598 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided therapy (ticagrelor for LOF carriers)
Number of subjects: 5302
Study 32840598 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (clopidogrel)
Number of subjects: 5302
Study 32840598 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided therapy (all randomized patients)
Number of subjects: 5302
Study 32840598 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (all randomized patients)
Number of subjects: 5302
Study 32840598 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided therapy (major or minor bleeding)
Number of subjects: 5302
Study 32840598 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (major or minor bleeding)
Number of subjects: 5302
Study 35427357 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Africa (intervention)
Number of subjects: 494
Study 35427357 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 494
Study 34192907 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based care platform (treatment group)
Number of subjects: 365
Study 34192907 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 365
Study 32818328 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy femtosecond laser pretreatment
Number of subjects: 40
Study 32818328 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification
Number of subjects: 40
Study 35024497 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-blocking glasses
Number of subjects: 30
Study 35024497 — intervention group
Group type: COMPARATOR
Intervention: Control glasses with partial blue-blocking effect
Number of subjects: 30
Study 34729065 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 80
Study 35654467 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotension Prediction Index (HPI) based treatment protocol
Number of subjects: 80
Study 35654467 — intervention group
Group type: COMPARATOR
Intervention: Standard haemodynamic parameters (Control)
Number of subjects: 80
Study 35654467 — intervention group
Group type: EXPERIMENTAL
Intervention: HemoSphere platform parameters (including dynamic arterial elastance, dP/dtmax, and HPI)
Number of subjects: 80
Study 35654467 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy technology for tissue oxygen saturation
Number of subjects: 80
Study 35654467 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarkers of acute kidney stress (cTIMP2 and IGFBP7)
Number of subjects: 80
Study 33875738 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostatic agent
Number of subjects: 0
Study 33875738 — intervention group
Group type: COMPARATOR
Intervention: Bipolar coagulation
Number of subjects: 0
Study 33875738 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostatic agent (in endometriosis patients)
Number of subjects: 0
Study 33875738 — intervention group
Group type: COMPARATOR
Intervention: Bipolar coagulation (in endometriosis patients)
Number of subjects: 0
Study 33095509 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 24
Study 33095509 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg of albuterol
Number of subjects: 24
Study 33095509 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg of albuterol
Number of subjects: 24
Study 35364589 — intervention group
Group type: EXPERIMENTAL
Intervention: Clazosentan (10 mg/hr)
Number of subjects: 220
Study 35364589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 33503629 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based individually tailored exercise program
Number of subjects: 118
Study 33503629 — intervention group
Group type: COMPARATOR
Intervention: Unspecified flexibility training (placebo control)
Number of subjects: 118
Study 33064137 — intervention group
Group type: EXPERIMENTAL
Intervention: Social risk screening with questions about interest in receiving assistance
Number of subjects: 1021
Study 35434578 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 µg RBD vaccine
Number of subjects: 792
Study 35434578 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 µg RBD vaccine
Number of subjects: 792
Study 35434578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 792
Study 35434578 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 µg RBD vaccine (long schedule)
Number of subjects: 792
Study 35434578 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 µg RBD vaccine (long schedule)
Number of subjects: 792
Study 35434578 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 µg RBD vaccine (phase 2)
Number of subjects: 792
Study 35434578 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 µg RBD vaccine (phase 2)
Number of subjects: 792
Study 35434578 — intervention group
Group type: COMPARATOR
Intervention: Placebo (phase 2)
Number of subjects: 792
Study 33342530 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional monthly SNAP benefits ranging from $1 to $122
Number of subjects: 2202
Study 35074044 — intervention group
Group type: EXPERIMENTAL
Intervention: psy-PAD (psychodynamically oriented short-term therapy program, eight sessions)
Number of subjects: 143
Study 35074044 — intervention group
Group type: COMPARATOR
Intervention: Optimized standard care (control condition)
Number of subjects: 143
Study 35074044 — intervention group
Group type: EXPERIMENTAL
Intervention: psy-PAD
Number of subjects: 143
Study 33355302 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 2605
Study 33355302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2605
Study 35202418 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (n = 52)
Number of subjects: 102
Study 35202418 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 50)
Number of subjects: 102
Study 35202418 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Vitamin D supplementation and Placebo)
Number of subjects: 102
Study 35202418 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 102
Study 35202418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 33611503 — intervention group
Group type: EXPERIMENTAL
Intervention: PNE plus cognition‐targeted exercises
Number of subjects: 0
Study 33611503 — intervention group
Group type: COMPARATOR
Intervention: Neck/back school plus general exercises
Number of subjects: 0
Study 35779558 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg once daily for 14 days
Number of subjects: 472
Study 35779558 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (no thromboprophylaxis)
Number of subjects: 472
Study 35779558 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 472
Study 35779558 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 472
Study 34432106 — intervention group
Group type: EXPERIMENTAL
Intervention: on!® nicotine pouches (NPs)
Number of subjects: 0
Study 34432106 — intervention group
Group type: COMPARATOR
Intervention: Own brand cigarettes (OBCs)
Number of subjects: 0